(Q47588275)

4 February 2018

title

Oral tolerance and autoimmune diabetes--will hope triumph over experience? (English)

1 reference

4 February 2018

author name string

E A Gale

series ordinal

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

4 February 2018

published in

The Lancet

1 reference

4 February 2018

volume

356

1 reference

4 February 2018

issue

9229

1 reference

4 February 2018

page(s)

526-527

1 reference

4 February 2018

Oral tolerance for the treatment of autoimmune diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902573-3

7 January 2021

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902573-3

7 January 2021

Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902573-3

7 January 2021

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902573-3

7 January 2021

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902573-3

7 January 2021

10.1016/S0140-6736(00)02573-3

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018